Recombinant Mouse Protrudin, also known as ZFYVE27, is a protein that belongs to the FYVE finger family. It plays a crucial role in membrane trafficking and is particularly important in neuronal cells for promoting neurite extensions and directional membrane trafficking . This protein is of significant interest due to its involvement in hereditary spastic paraplegia (HSP), specifically subtype SPG33 .
ZFYVE27 contains several structural domains, including a Rab11 binding domain (RBD11), a FYVE domain, a FFAT motif, a coiled-coil domain, and three hydrophobic regions (HR) . These domains facilitate its role in membrane-cargo trafficking by interacting with proteins like spastin and Rab11 . The protein is known to form oligomers, which are essential for its function in promoting neurite extensions .
Recombinant Mouse Protrudin can be produced in various expression systems, including yeast, E. coli, baculovirus, and mammalian cells . The choice of expression system depends on the desired level of protein purity and post-translational modifications required for the protein's biological activity.
ZFYVE27 is crucial for directional membrane trafficking in neurons, promoting neurite outgrowth and extension . Its interaction with Rab11 and spastin highlights its importance in regulating vesicular transport processes .
Mutations in ZFYVE27 are associated with hereditary spastic paraplegia subtype SPG33, emphasizing its role in neurodegenerative diseases . Studies using mouse models have been instrumental in understanding the molecular mechanisms underlying this condition .
Beyond its role in neurons, ZFYVE27 also modulates seizure activity through GABA A receptor regulation and influences endothelial cell migration and angiogenesis .
Protrudin (Zfyve27) is a key regulator of RAB11-dependent vesicular trafficking during neurite extension, mediated by polarized membrane transport. It promotes axonal elongation and neuronal polarity establishment. In a VAPA-dependent manner, it facilitates nerve growth factor-induced neurite formation. Furthermore, it contributes to both the formation and stabilization of the tubular endoplasmic reticulum (ER) network, influencing ER morphogenesis by regulating the sheet-to-tubule balance and potentially the density of tubule interconnections. Functioning as an adapter protein, it facilitates the interaction of KIF5A with VAPA, VAPB, SURF4, RAB11A, RAB11B, and RTN3. The ZFYVE27-KIF5A complex is involved in the transport of these proteins in neurons. Importantly, it can induce neurite-like membrane protrusions in non-neuronal cells in a KIF5A/B-dependent manner.
Protrudin (Zfyve27) is a novel member of the FYVE-finger family of proteins that was originally identified as an interacting partner of spastin, which is frequently mutated in hereditary spastic paraplegia . The protein contains several functional domains including a Rab11 binding domain (RBD11) in its N-terminal region, a FYVE domain in its C-terminal end, a FFAT motif, a coiled-coil domain, and three hydrophobic region (HR) motifs in the central portion of the protein . These structural features are characteristic of proteins involved in membrane-cargo trafficking.
Subcellular localization studies using epitope-tagged constructs (E2-ZFYVE27 or GFP-ZFYVE27) demonstrate that Protrudin is predominantly expressed in punctate vesicles within cells . Biochemical analyses including subcellular fractionation and Triton X-114 membrane phase separation indicate that ZFYVE27 is a peripheral membrane protein that binds to phosphatidylinositol 3-phosphate lipid moiety .
Protrudin plays a crucial role in promoting neurite extension through directional membrane trafficking . It acts in concert with Rab11, a small GTPase that regulates membrane traffic at the trans-Golgi network-recycling endosome boundary and recycles them back to the plasma membrane . This coordinated activity is essential for directional membrane transport during neurite formation.
Experimental evidence shows that overexpression of ZFYVE27 in PC12 cell lines and primary hippocampal neurons leads to extensive neurite outgrowth . Conversely, downregulation of endogenous ZFYVE27 in PC12 cells by RNA interference results in inhibition of neurite outgrowth even after nerve growth factor induction and causes swelling of cell soma . These findings demonstrate that Protrudin is a critical determinant of neuronal differentiation and development.
Protrudin forms functional oligomers, specifically dimers or tetramers, which are essential for its biological activity . The oligomerization of ZFYVE27 was initially discovered through a yeast two-hybrid screen that identified ZFYVE27 as its own interaction partner . This self-interaction was subsequently confirmed in mammalian cells using co-immunoprecipitation and co-localization studies .
Sucrose gradient centrifugation experiments revealed that ZFYVE27 oligomerizes into dimer/tetramer forms . The core interaction region between Protrudin monomers was mapped to the third hydrophobic region (HR3, amino acids 185-207) of the protein through deletion construct analysis in yeast two-hybrid assays . Importantly, cells expressing ZFYVE27 with deleted HR3 motif (ZFYVE27 ΔHR3) fail to produce cellular protrusions and instead exhibit swelling of cell soma, indicating that oligomerization is necessary for Protrudin's ability to promote neurite extensions .
Mutations in ZFYVE27 have been linked to hereditary spastic paraplegia (HSP), specifically the autosomal dominant form (AD-HSP) . A German family with AD-HSP was found to have a mutation in ZFYVE27, designated as SPG33 . The mutated ZFYVE27 protein shows an aberrant intracellular pattern in its tubular structure, and its interaction with spastin is severely affected .
The specific mutation in ZFYVE27 is postulated to affect neuronal intracellular trafficking in the corticospinal tract, which is consistent with the pathology of HSP . This finding connects Protrudin dysfunction with impaired axonal transport, which has been implicated in numerous neurodegenerative disorders. The SPG33 form appears to be a pure form of HSP, and ZFYVE27 has been excluded as a candidate gene for the SPG27 subtype of the disease .
Several complementary techniques can be employed to study Protrudin oligomerization:
Yeast Two-Hybrid Analysis:
Generate a bait construct with full-length human ZFYVE27 cDNA cloned into appropriate vectors (e.g., pGBKT7)
Transform into yeast strain (e.g., AH109) and test for auto-activation of reporter genes
Perform direct-Y2H assay with ZFYVE27 constructs to confirm self-interaction
Co-immunoprecipitation in Mammalian Cells:
Create epitope-tagged ZFYVE27 constructs (e.g., GFP-ZFYVE27, FLAG-ZFYVE27)
Co-transfect differentially tagged constructs into mammalian cells
Perform immunoprecipitation with tag-specific antibodies
Sucrose Gradient Centrifugation:
Prepare cell lysates containing ZFYVE27
Subject lysates to sucrose gradient centrifugation (e.g., 5-20% sucrose gradient)
Collect fractions and analyze by Western blotting
Compare migration patterns with known molecular weight markers to determine oligomeric state
Fluorescence Resonance Energy Transfer (FRET):
Generate fluorescent protein-tagged ZFYVE27 constructs (e.g., CFP-ZFYVE27, YFP-ZFYVE27)
Perform live-cell imaging to detect energy transfer between fluorophores
Calculate FRET efficiency to quantify protein-protein interactions
To investigate Protrudin's association with membranes, researchers can utilize these methodological approaches:
Subcellular Fractionation:
Homogenize cells expressing ZFYVE27 in appropriate buffer
Separate cellular components by differential centrifugation
Analyze distribution of ZFYVE27 across cytosolic, membrane, and nuclear fractions by Western blotting
Triton X-114 Membrane Phase Separation:
Treat cell lysates with Triton X-114 at 4°C
Warm samples to 37°C to induce phase separation
Separate aqueous and detergent phases
Analyze presence of ZFYVE27 in each phase to determine membrane association properties
Lipid Binding Assays:
Prepare liposomes containing various phosphoinositides
Incubate with purified recombinant ZFYVE27
Pellet liposomes and analyze bound proteins
Particularly focus on phosphatidylinositol 3-phosphate binding via the FYVE domain
Confocal Microscopy with Membrane Markers:
Co-express fluorescently tagged ZFYVE27 with established membrane markers
Perform live-cell or fixed-cell confocal microscopy
Quantify colocalization using appropriate image analysis software
When investigating Protrudin mutants, particularly those lacking the HR3 domain or containing disease-associated mutations, consider these approaches:
Dominant-Negative Effect Analysis:
Co-express wild-type ZFYVE27 with mutant variants (e.g., ZFYVE27 ΔHR3)
Assess cellular phenotypes using microscopy techniques
Quantify changes in neurite extension, cell morphology, and protein localization
Analyze cytoplasmic swelling as a readout of disrupted function
Neurite Outgrowth Assays:
Express ZFYVE27 variants in neuronal cell lines (e.g., PC12) or primary neurons
Induce differentiation (e.g., with nerve growth factor for PC12 cells)
Quantify neurite length, number, and branching pattern
Compare mutant phenotypes to wild-type and negative controls
Interaction Studies with Spastin:
Perform co-immunoprecipitation of ZFYVE27 variants with spastin
Quantify interaction efficiency using Western blotting
Utilize FRET or proximity ligation assays to assess interactions in intact cells
Compare binding of disease-associated mutants to determine functional consequences
Live-Cell Trafficking Analysis:
Generate fluorescently tagged ZFYVE27 variants
Perform time-lapse microscopy to track vesicle movement
Analyze trafficking dynamics including velocity, directionality, and processivity
Correlate trafficking defects with cellular phenotypes
For effective neuronal studies of Protrudin function, consider these methodological approaches:
Primary Neuronal Cultures:
Isolate and culture primary neurons (hippocampal, cortical, or motor neurons)
Transfect or transduce neurons with ZFYVE27 constructs
Analyze neurite outgrowth, branching, and neuronal morphology
Implement time-lapse imaging to track dynamic changes in neurite extension
In Vivo Models:
Generate transgenic mouse models with ZFYVE27 modifications (knockout, knockin of specific mutations)
Analyze corticospinal tract development and maintenance
Assess motor function using behavioral assays relevant to HSP
Perform histological analyses of neuronal morphology and axonal integrity
Rab11 Interaction Studies:
Co-express ZFYVE27 with wild-type and mutant Rab11 (constitutively active or dominant negative)
Analyze effects on ZFYVE27 localization and function
Quantify changes in vesicle trafficking and neurite extension
Identify key regulatory mechanisms in the ZFYVE27-Rab11 pathway
Axonal Transport Assays:
Express fluorescently tagged cargo proteins in neurons with modified ZFYVE27 expression
Perform live-cell imaging of cargo transport along axons
Quantify transport parameters (velocity, run length, pause frequency)
Correlate transport defects with neuronal development and maintenance
For researchers working with recombinant Protrudin, these purification and analysis methods are recommended:
Expression Systems:
Use prokaryotic systems (E. coli) for expression of soluble domains
Employ eukaryotic systems (insect cells, mammalian cells) for full-length protein
Consider cell-free systems for proteins that may be toxic to host cells
Optimize expression conditions to maximize protein yield and solubility
Purification Strategy:
Design constructs with appropriate tags (His, GST, MBP) to facilitate purification
Implement multi-step purification protocol including affinity chromatography, ion exchange, and size exclusion
Verify protein identity by mass spectrometry
Assess protein quality using dynamic light scattering and thermal shift assays
Functional Validation:
Perform lipid binding assays to confirm interaction with phosphatidylinositol 3-phosphate
Analyze oligomerization state using analytical ultracentrifugation or multi-angle light scattering
Conduct in vitro interaction studies with binding partners including spastin and Rab11
Validate functional activity through reconstitution assays in membrane systems
Structural Analysis:
Apply X-ray crystallography or cryo-electron microscopy for high-resolution structure determination
Use small-angle X-ray scattering (SAXS) to analyze oligomeric assemblies in solution
Implement nuclear magnetic resonance (NMR) for dynamic studies of specific domains
Apply hydrogen-deuterium exchange mass spectrometry to map protein-protein interaction interfaces